Intraocular Gutless Adenoviral-Vectored VEGF Stimulates Anterior Segment but not Retinal Neovascularization

Journal of Cellular Physiology

Volumn 199, Issue 3, 2004, Pages 399-411

  Oshima, Yuji ^a   Takahashi, Kyoichi ^a   Oshima, Sachiko ^a   Saishin, Yoshitsugu ^a   Saishin, Yumiko ^a   Lima Silva, Raquel ^a   Liang, Xaoling ^a   Reddy, P Seshidhar ^b   Ganesh, Shanthi ^b   Brann, Terrence ^b   Liau, Gene ^b   Kaleko, Michael ^a,c   Connelly, Sheila ^b   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Advanced Vision Therapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; GENE; GENE EXPRESSION; GENE TRANSFER; GUTLESS ADENOVIRUS VECTOR; IGF1 GENE; IN VIVO STUDY; IRIS NEOVASCULARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CAPILLARY; RETINA INJURY; RETINA NEOVASCULARIZATION; SPK GENE; VEGF GENE;

ADENOVIRIDAE; ANIMALS; DNA PRIMERS; EYE; GENETIC VECTORS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LAC OPERON; LYSOPHOSPHOLIPIDS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RETINAL NEOVASCULARIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOSINE; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2342592123     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10441     Document Type: Article

References (52)

1. Adamis AP, Miller JW, Bernal M-T, D'Amico DJ, Folkman J, Yeo T-K, Yeo K-T. 1994. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450.
2. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen MS, Aiello LM, Ferrara N, King GL. 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
3. Ancellin N, Colmont C, Su J, Li Q, Mittereder N, Chae S-S, Stefansson S, Liau G, Hla T. 2002. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 277:6667-6675.
4. Balague C, Zhou J, Dai Y, Alemany R, Josephs SF, Andreason G, Hariharan M, Sethi E, Prokopenko E, Jan HY, Lou YC, Jubert-Leslie D, Ruiz S, Zhang WW. 2000. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemiophilic mice using a minimal adenovirus vector. Blood 95: 820-828.
5. Barile GR, Chang S, Horowitz JD, Reppucci VS, Schiff WM, Wong DT. 1998. Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery. Am J Ophthalmol 126:379-389.
6. Blankenship G. 1980. The lens influence on diabetic vitrectomy results. Report of a prospective randomized study. Arch Ophthalmol 98:2196-2198.
7. Blankenship G, Cortez R, Machemer R. 1979. The lens and pars plans vitrectomy for diabetic retinopathy complications. Arch Ophthalmol 97:1263-1267.
8. Bopp S, Lucke K, Laqua H. 1992. Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment. Ger J Ophthalmol 1:375-381.
9. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ. 2002. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 43:821-829.
10. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG. 2000. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 14:2255-2265.
11. Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koos RD, Semenza G. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
12. Gerber H-P, Condorelli F, Park J, Ferrara N. 1997. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272:23659-23667.
13. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1842-1849.
14. 2 homeostasis by hypoxia-inducible factor 1alpha. Genes Dev 12:149-162.
15. Kochanek S. 1999. High capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 10:2451-2459.
16. Kochanek S, Schiedner G, Volpers C. 2001. High-capacity "gutless" adenoviral vectors. Curr Opin Mol Ther 3:454-463.
17. Kreppel F, Luther TT, Semkova I, Schraermeyer U, Kochanek S. 2002. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector. Invest Ophthalmol Vis Sci 43: 1965-1970.
18. Kumar-Singh R, Chamberlain JS. 1996. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum Mol Genet 5:913-921.
19. Kumar-Singh R, Farber DB. 1998. Encapsidated adenovirus minichromosome-mediated delivery of genes to the reina: Application to the rescue of photoreceptor degeneration. Hum Mol Genet 7:1893-1900.
20. Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, Kim JH, Kwon YG. 1999. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical bein endothelial cells. Biochem Biophys Res Comm 264:743-750.
21. Maione D, Della Rocca C, Giannetti P, D'Arrigo R, Liberatoscioli L, Franlin LL, Sandig V, Ciliberto G, La Monica N, Savino R. 2001. An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus. Proc Natil Acad Sci USA 98:5986-5991.
22. Miller JW, Stinson W, Folkman J. 1993. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 100:9-14.
23. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, Yeo T-K, Yeo K-T. 1994. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584.
24. Mittereder N, March KL, Trapnell BC. 1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70:7498-7509.
25. Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA. 2001. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188:253-263.
26. Mori K, Gehlbach P, Ando A, Wahlin K, Gunther V, McVey D, Wei L, Campochiaro PA. 2002a. Intraocular adenoviral vector-mediated gene transfer is increased in proliferative retinopathies. Invest Ophthalmol Vis Sci 43:1610-1615.
27. Mori K, Gehlbach P, Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA. 2002b. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43: 1994-2000.
28. Morral N, Parks RJ, Zhou H, Langston C, Schiedner G, Quinones J, Graham FL, Kochanek S, Beaudet AL. 1998. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha 1-antitrypsin with negligible toxicity. Hum Gene Ther 9:2709-2716.
29. Morral N, O'Neal W, Rice K, Leland M, Kaplan J, Piedra PA, Zhou H, Parks RJ, Velji R, Aguilar-Cordova E, Wadsworth S, Graham FL, Kochanek S, Carey KD, Beaudet AL. 1999. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci USA 96:12816-12821.
30. Morsy MA, Gu M, Motzel S, Zhao J, Lin J, Su O, Allen H, Franlin L, Parks RJ, Graham FL, Kochanek S, Bett AJ, Caskey CT. 1998. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci USA 95:7866-7871.
31. Murphy RP, Egbert PR. 1979. Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 97:700-702.
32. Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P, Duh EJ, Hackett SF, Chang M, Bok D, Zack DJ, Campochiaro PA. 2002. Inducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 160: 711-719.
33. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA. 1997. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281-91.
34. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima K. 1997. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 64:505-17.
35. Parks RJ, Graham FL. 1997. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J Virol 71:3293-3298.
36. Parks RJ, Chen S, Anton M, Sankar U, Rudnicki MA, Graham FL. 1996. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 93:13565-13570.
37. Pavan PR, Folk JC, Weingeist TA, Hermsen VM, Watzke RC, Montague PR. 1983. Diabetic rubeosis and panretinal photocoagulation. Arch Ophthalmol 101:882-884.
38. Pournaras C, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. 1990a. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 97:1321-1328.
39. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. 1990b. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 97:1329-1333.
40. Reddy PS, Sakhuja K, Ganesh S, Yang L, Kayda D, Brann T, Pattison S, Golightly D, Idamakanti N, Pinkstaff A, Kaloss M, Barjot C, Chamberlain JS, Kaleko M, Connelly S. 2002. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Molec Ther 5: 63-73.
41. Sadiq SA, Chatterjee A, Vernon SA. 1995. Progression of diabetic retinopathy and rubeotic glaucoma following cataract surgery. Eye 9:728-738.
42. Sandig V, Youil R, Bett AJ, Franlin LL, Oshima M, Maione D, Wang F, Metzker ML, Savino R, Caskey CT. 2000. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci USA 97:1002-1007.
43. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180-183.
44. Scuderi JJ, Blumenkranz M, Blankenship G. 1982. Regression of diabetic rubeosis iridis following successful surgical reattachment of the retina by vitrectomy. Retina 2:193-196.
45. Stefansson E, Landers MBI, Wolbarsht ML, Klintworth GK. 1984. Neovascularization of the iris: an experimental model in cats. Invest Ophthalmol Vis Sci 25:361-364.
46. Takahashi K, Saishin Y, Saishin Y, Lima Silva R, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ, Liau G, Kaleko M, Connelly S, Luo T, Campochiaro PA. 2003. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J 17:896-898 and full version online at 10.1096/fj.02-0824fje.
47. Tasman W, Magargal LE, Augsburger JJ. 1980. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 87:400-402.
48. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA. 1998. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180-188.
49. Toietta G, Pastore L, Cerullo V, Finegold M, Beaudet AL, Lee B. 2002. Generation of helper-dependent adenoviral vectors by homologous recombination. Mol Ther 5:204-210.
50. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. 1996. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 114:964-970.
51. Wand M, Dueker DK, Aiello LM, Grant WM. 1978. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol 86:332-339.
52. Wang F, Van Brocklyn JR, Hobson JP, Movafagh S, Zukowska-Grojec Z, Milstien S, Spiegel S. 1999. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274:35343-35350.